John Pollard
Company: Bayer
Job title: Global Head Early Clinical Development & Translational Medicine Oncology
Seminars:
Panel Discussion: What is the Role of DDR-targeted Therapies in the Wider Oncology Portfolio? 4:45 pm
day: Day Two
Inhibition of ATR: Progress from the Lab to the Clinic 9:30 am
day: Day Two